| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.42M | 20.50M | 19.70M | 15.06M | 17.13M | 14.83M |
| Gross Profit | 10.19M | 9.74M | 9.84M | 7.65M | 8.61M | 7.00M |
| EBITDA | 2.65M | 2.23M | 2.34M | 1.30M | 3.34M | 1.85M |
| Net Income | 1.58M | 1.27M | 1.44M | 635.90K | 2.54M | 1.12M |
Balance Sheet | ||||||
| Total Assets | 23.93M | 23.41M | 23.13M | 20.17M | 17.63M | 16.42M |
| Cash, Cash Equivalents and Short-Term Investments | 11.72M | 11.93M | 11.85M | 11.44M | 10.71M | 8.65M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00M |
| Total Liabilities | 4.80M | 5.62M | 6.85M | 5.54M | 3.88M | 5.47M |
| Stockholders Equity | 19.13M | 17.79M | 16.28M | 14.63M | 13.74M | 10.95M |
Cash Flow | ||||||
| Free Cash Flow | -811.23K | 56.22K | 369.18K | 769.17K | 1.99M | 374.83K |
| Operating Cash Flow | -564.64K | 525.02K | 1.16M | 1.33M | 2.32M | 725.19K |
| Investing Cash Flow | -1.99M | 2.55M | -2.38M | -2.81M | -1.63M | -594.58K |
| Financing Cash Flow | -148.38K | -7.87K | 0.00 | 0.00 | 68.78K | 293.92K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $57.01M | 8.59 | 178.77% | ― | 30.11% | 481.67% | |
66 Neutral | $72.03M | 20.77 | 9.37% | ― | 2.21% | -15.60% | |
64 Neutral | $84.86M | -116.26 | -3.84% | ― | 38.22% | 70.68% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | $66.45M | 42.26 | 8.45% | ― | -0.21% | -0.41% | |
49 Neutral | $276.90M | -92.36 | -27.25% | ― | -44.83% | -296.14% | |
44 Neutral | $34.66M | -18.33 | -87.36% | ― | -16.49% | -59.21% |
On January 13, 2026, Sono-Tek reported its fiscal third-quarter and nine-month 2026 results for the period ended November 30, 2025, showing stable revenue but significantly improved profitability and margins. Quarterly net sales edged down 4% to $5.0 million yet marked a seventh straight quarter above the $5 million mark, while gross margin expanded to 50% and net income rose 24% to $340,000; for the first nine months, sales were essentially flat at $15.3 million, but gross margin improved to 51% and net income climbed 32% to $1.25 million. The company ended the quarter debt-free with $11.7 million in cash and securities and a record $12.26 million backlog, reflecting strong order momentum driven by high-ASP production systems, medical, electronics and industrial demand, even as policy-driven softness in U.S. alternative energy and electrolysis markets weighed on some product categories and regions. Management highlighted strong growth in in-line coating, OEM and fluxing systems, robust medical and industrial sales, and a mixed geographic picture with higher North American sales offset by declines in Asia Pacific, Latin America and EMEA, underscoring Sono-Tek’s strategic shift toward higher-margin systems and its reinforced positioning for continued, if modest, top-line growth.
The most recent analyst rating on (SOTK) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Sono-Tek stock, see the SOTK Stock Forecast page.
On October 14, 2025, Sono-Tek Corporation announced its financial results for the second quarter and first half of fiscal year 2026, reporting a sixth consecutive quarter with revenues exceeding $5 million. The company experienced a 150% annual increase in medical market sales, a 35% rise in net income for the first half, and a 50% sequential increase in backlog, reflecting strong order momentum. Sono-Tek updated its fiscal year 2026 guidance, anticipating modest revenue growth due to increasing demand in the medical device market, despite challenges in the clean energy sector. The company remains focused on its long-term growth strategy, supported by a strong balance sheet and robust customer demand.
On November 5, 2025, Sono-Tek Corporation restructured its executive agreements with key officers, including the CEO, Executive Chairman, CFO, and COO. The new agreements, which replace the original ones, maintain similar terms but include an expanded definition of ‘Resignation for Good Reason’ and other modifications, potentially impacting the company’s leadership stability and stakeholder confidence.